Skip to main content
. 2019 Nov 27;10:1392. doi: 10.3389/fphar.2019.01392

Figure 3.

Figure 3

Chloroquine effects on persistent AF. (A) Daily AF burden for 14 days in Holter monitoring at baseline, and for 14 days upon initiation of oral chloroquine (amebiasis treatment regimen). (B) 12 lead ECG on the day of chloroquine initiation, confirming the presence of AF. (C) Holter ECG strips from baseline (top), right before treatment initiation (middle), and on the 3rd day of treatment when AF converted to sinus rhythm (bottom).